KB Home (KBH) (FINL) (HR) (IDIX) (LOGM) (MJN) Ratings Reiterated

KB Home (NYSE: KBH), Finish Line (NASDAQ: FINL), Healthcare Realty Trust (NYSE: HR), Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), LogMeIn Inc. (NASDAQ: LOGM) and Mead Johnson Nutrition (NYSE: MJN) had ratings on them reiterated by analysts.

Jefferies Group reiterated its "Buy" rating on Finish Line (FINL).

Stifel Nicolaus reiterated its "Hold" rating on Healthcare Realty Trust (HR).

Brean Murray Carret & Co. reiterated its "Sell" rating on Idenix Pharmaceuticals, Inc. (IDIX).

Deutsche Bank (NYSE:DB) reiterated its "Hold" rating on KB Home (KBH). They have a price target of $9.00 on the company.

Piper Jaffray (NYSE:PJC) reiterated its "Overweight" rating on LogMeIn Inc. (LOGM). They have a price target of $50.00 on the company.

Goldman Sachs (NYSE:GS) reiterated its "Neutral" rating on Mead Johnson Nutrition (MJN).